Overview of congenitally and perinatally acquired cytomegalovirus infections: recent advances in antiviral therapy.
about
Risk factors for and clinical outcome of congenital cytomegalovirus infection in a peri-urban West-African birth cohort.Recent advances in designing an effective vaccine to prevent cytomegalovirus-associated clinical diseases.Progress toward an elusive goal: current status of cytomegalovirus vaccines.Cyclic cidofovir (cHPMPC) prevents congenital cytomegalovirus infection in a guinea pig modelCMV-induced embryonic mouse organ of corti dysplasia: Network architecture of dysfunctional lateral inhibition.VCL-CB01, an injectable bivalent plasmid DNA vaccine for potential protection against CMV disease and infection.Antiviral therapy for herpesvirus central nervous system infections: neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection.The non-nucleoside antiviral, BAY 38-4766, protects against cytomegalovirus (CMV) disease and mortality in immunocompromised guinea pigsLetermovir Treatment of Human Cytomegalovirus Infection Antiinfective Agent.Evaluation of intratympanic formulations for inner ear delivery: methodology and sustained release formulation testing.Fetal ascites owing to congenital cytomegalovirus: response to ganciclovir.Encephalitis, acute renal failure, and acute hepatitis triggered by a viral infection in an immunocompetent young adult: a case report.Severe postnatal cytomegalovirus infection with multisystem involvement in an extremely low birth weight infant.Nonimmune hydrops fetalis and fulminant fatal disease due to congenital cytomegalovirus infection in a premature infant.Successful renal transplantation during pregnancy.Pyrosequencing allows the detection of emergent ganciclovir resistance mutations after HCMV infection.Cytomegalovirus infection of human syncytiotrophoblast cells strongly interferes with expression of genes involved in placental differentiation and tissue integrity.Successful treatment with oral valganciclovir in immunocompetent infant with gastrointestinal manifestations of cytomegalovirus infection.
P2860
Q33286814-9C016EA3-ED55-4C76-82FA-878E1978C569Q34349745-20B72B9A-ACAB-41C3-9C83-DF00C066C32FQ34434818-DEBF7DA2-71C3-4A3B-A3D1-1DF67140CFECQ34885438-6B4CF00D-1DE9-4367-9341-2043AADB6AADQ35875979-2DB4C711-B92A-4E9D-AD51-184C36059BF4Q36517156-284CE12A-90F4-4FD9-850D-549A10D8726EQ37357122-E1E42A8F-F334-46A3-A1A0-876A3ADA6D0FQ37401583-6D05EA53-F0C4-44AB-9B83-ECE67C2A19B5Q39325580-284E0AF6-FF77-491C-B937-240A0997EFE0Q41856899-A2838EDD-BF2D-4B38-B69F-BC5D9FF57674Q41938833-0A3EB66C-42FD-4131-B06D-C67ADB040698Q42940853-52057287-1E04-483F-9B90-CCF7448148BFQ44309537-32EC90CD-8962-40AC-AD54-FF2F912467C4Q44923353-2B7E9AF1-CFF1-4FB4-BA52-EF742D188EE5Q46646000-BDD6AC69-DDA8-480E-AB8A-526399050BB2Q52899787-4A0970BA-D7D0-49FD-A631-DB628DC11156Q53561045-6FABCFE7-FC2D-42C8-A666-ECE1C82A2FCAQ54579094-4463882A-44EA-4E43-9D67-C197ABC11D43
P2860
Overview of congenitally and perinatally acquired cytomegalovirus infections: recent advances in antiviral therapy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Overview of congenitally and p ...... advances in antiviral therapy.
@ast
Overview of congenitally and p ...... advances in antiviral therapy.
@en
type
label
Overview of congenitally and p ...... advances in antiviral therapy.
@ast
Overview of congenitally and p ...... advances in antiviral therapy.
@en
prefLabel
Overview of congenitally and p ...... advances in antiviral therapy.
@ast
Overview of congenitally and p ...... advances in antiviral therapy.
@en
P2860
P356
P1476
Overview of congenitally and p ...... advances in antiviral therapy.
@en
P2093
Mark R Schleiss
Michael A McVoy
P2860
P304
P356
10.1586/14787210.2.3.389
P577
2004-06-01T00:00:00Z